|
6.7.2015 |
EN |
Official Journal of the European Union |
C 221/20 |
Order of the General Court of 30 April 2015 — Alnapharm v OHIM — Novartis (Alrexil)
(Case T-839/14) (1)
((Community trade mark - Opposition proceedings - Withdrawal of the opposition - No need to adjudicate))
(2015/C 221/27)
Language of the case: English
Parties
Applicant: Alnapharm GmbH & Co. KG (Hamburg, Germany) (represented by: H. Heldt, lawyer)
Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: H. O'Neill, acting as Agent)
Other party to the proceedings before the Board of Appeal of OHIM: Novartis AG (Basel, Switzerland)
Re:
Action brought against the decision of the Fourth Board of Appeal of OHIM of 23 October 2014 (Case R 1723/2013-4) concerning opposition proceedings between Novartis AG and Alnapharm GmbH & Co. KG.
Operative part of the order
|
1. |
There is no longer any need to adjudicate in the action. |
|
2. |
The applicant and the other party to the proceedings before the Board of Appeal shall bear their own costs and shall each pay half of the costs incurred by the defendant. |